Bayer announces positive results from phase III REVEAL study of investigational PET/CT radiotracer 124 evuzamitide: Berlin, Germany Friday, May 8, 2026, 16:00 Hrs [IST] Bayer anno ...

Bayer today announced positive topline results from the Phase III REVEAL study, an investigator-initiated study by Brigham and Women’s Hospital that evaluated the investigational PET/CT radiotracer I ...

This trial is looking at whether doctors can use PSMA PET-CT scans to guide treatment for people who have high risk prostate cancer.

Armed with new phase 3 data, Bayer is preparing to file for approval of a new PET imaging agent that could accelerate the ...

Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with a single‑assay design, intended to rule in ...

The Social Health Authority has increased annual cancer cover for patients by Sh250,000 to Sh800,000 in a move aimed at easing the financial burden on affected families.The expanded cancer benefits ...

Chairman BR Naidu said the State government is taking steps to develop Sri Venkateswara Institute of Medical Sciences (SVIMS) ...

The facilities were inaugurated by Tirumala Tirupati Devasthanams (TTD) chairman B.R. Naidu under the Sri Balaji ...

Aspirus Wausau Hospital held a groundbreaking ceremony for the current expansion project to the hospital.

A new veterinary hospital opened in Melton Mowbray this morning (Monday) after hundreds of people visited the impressive site ...

Hine’s heirs include Charles Sheeler, W. Eugene Smith, Bernd and Hilla Becher, Sebastião Salgado, and Edward Burtynsky. Add ...

Elecsys pTau217 is the first blood test for Alzheimer's disease pathology with a single-assay design, intended to rule in and rule out amyloid pathology across primary and secondary care, offering fas ...